Guangzhou Boji Medical&Biotechnological Co.,Ltd.’s Net Profit Rose 10.2% in First Half of 2021

Guangzhou Boji Medical&Biotechnological Co.,Ltd. (广州博济医药生物技术股份有限公司) (300404.SZ) reported a net profit of 16.4 million yuan in the first half of 2021, up 10.2% year-on-year.

Meanwhile, the company posted 120.8 million yuan in revenue, up 9.7% year-on-year.

At the end of the reporting period, it had 1.1 billion yuan in total assets and 285.7 million yuan in total liabilities, with a liability-to-asset ratio of 26.3%.

This article was automatically produced by Caixin Automation on Sept. 1, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.